Lallemand Health Solutions a vertically integrated lab to shelf probiotic manufacturer is a gold sponsor of Microbiome Probiotics Europe taking place at the Postilion Convention Centre in Rotterdam from May 21-22, 2019. We invite you to stop by our booth and speak with our team to discuss the latest scientific research and probiotic innovation information in the brain-gut axis, gut health, immunity, and women’s health. Sylvie Morin, Director of Strategic Business Development will also be on-hand to discuss potential partnership and licensing opportunities.
Don’t Miss Dr. Wendy J. Dahl’s Presentation on Prader Willi Syndrome on May 21 at 9:35 a.m.
Dr. Wendy J. Dahl, Associate Professor in the Food Science and Human Nutrition Department at the University of Florida present the first-ever randomized controlled clinical trial results evaluating the effectiveness of B. lactis LAFTI® B94 in adults with Prader-Willi syndrome. Dr. Dahl’s presentation focuses on the gastrointestinal aspects of the adult population that suffer from this syndrome.
We’ve got News on the Brain-Gut Axis and PROBIO’STICK®
Our team has new clinical studies and mechanistic data to share about the brain-gut axis. Did you know that we pioneered the first-ever clinical study on the brain-gut axis which demonstrated a probiotic formula promoted a positive mood during stressful events? We further documented the specific benefits of three probiotic combinations or strains (Probio’Stick®, Lacidofil® and Bifidobacterium bifidum Rosell®-71) with an exceptional track-record of publications: 17 mechanistic studies and five clinical studies. When it comes to the field of the brain-gut axis and understanding the impact and science that probiotics play on human health, we’re your go-to resource.
Did you Miss the Rosell Institute for Microbiome and Probiotics by Lallemand, SCIX Event?
At Lallemand Health Solutions science is behind everything that we do. We’re proud that Dr. Thomas Tompkins is the Chairperson of SCIX a two-day scientific symposium sponsored by the Rosell Institute that takes place each year in Montreal, Canada. SCIX provides an opportunity for the scientific community to have an open dialogue, share new scientific discoveries and advances in probiotics as well as create new partnerships. Take a look at the video here.
About Lallemand Inc.
Lallemand Inc. is a privately owned Canadian company specialising in the development, production, and marketing of yeast and bacteria and other ingredients linked to these microorganisms or their markets.
Lallemand Health Solutions. Quality Probiotic. Complete Solutions.
Founded in 1934, Lallemand Health Solutions is a vertically integrated probiotic manufacturer specializing in the research, development, and manufacturing of ready-to-market and custom probiotic formulations. Our products target specific populations and health segments that include gut health, natural defenses, women’s health, brain-gut axis, oral health, and sport. Products include a range of 500+ ready-to-market Expert’Biotics™ that use our proprietary Lacidofil®, ProbioKid®, Probio’Stick®, and IBacilluS+ formulas and customizable Smart’Biotics™, Unique’Biotics™ and Combocap®’Biotics which are created using our Harmonium, Lafti® or Rosell® strains and different ingredients. We have two research and development laboratories; an Applied Research facility located in Toulouse, France, and the Rosell® Institute for Microbiome and Probiotics in Montreal, Canada. Our dedicated probiotic production plants are certified to the highest quality standards: cGMP, Pharma GMP, Health Canada (NNHPD), USP Quality Systems GMP audited (Canada), ISO 9001 and ISO 22000 (France). Lallemand Health Solutions products are available in 60+ countries across five continents and is ready to service your probiotic needs.